Michael Schrago Email & Phone Number
Who is Michael Schrago? Overview
A concise factual answer block for searchers comparing this professional profile.
Michael Schrago is listed as Legal Officer at ABC GENETICS, a with 2 employees, based in Geneva, Switzerland. AeroLeads shows a matched LinkedIn profile for Michael Schrago.
Michael Schrago previously worked as Board Member at Ipsum Clinical and Director of Clinical Operations at Ipsum Clinical. Michael Schrago holds Master Of Science (Msc) In Medical Biology, Specialization In Pharmacology from University Of Lausanne - Unil.
Email format at ABC GENETICS
This section adds company-level context without repeating Michael Schrago's masked contact details.
Review company-level records connected to Michael Schrago before choosing the right outreach path.
About Michael Schrago
Dedicated and seasoned clinical trial professional with an extensive background in orchestrating successful studies and spearheading the development of robust clinical trial sites. Possessing a profound understanding of the intricate landscape of clinical research, I bring a wealth of experience in navigating regulatory frameworks, optimizing operational efficiencies, and ensuring the highest standards of patient care.
Listed skills include Biotechnology, Molecular Biology, Lifesciences, Biochemistry, and 44 others.
Michael Schrago's current company
Company context helps verify the profile and gives searchers a useful next step.
Michael Schrago work experience
A career timeline built from the work history available for this profile.
Board Member
Current• Provided strategic guidance, resulting in improved operational efficiency and alignment with organizational goals.• Directed financial oversight, leading to a 63% average annual percentage growth rate while maintaining full compliance with regulatory frameworks.• Represented Ipsum Clinical in high-profile stakeholder meetings, successfully securing new clinical trial partnerships with major pharma companies.• Advised on strategic decisions regarding site acquisition and new trials.
Director Of Clinical Operations
• Led the development and certification of 6 clinical trial sites through strategic joint ventures with hospitals and clinics.• Provide leadership and experience in the planning, implementation, and execution of clinical studies.• Ensure all clinical studies are conducted in accordance with company SOPs, GCPs and ICH guidelines.• Collaborated with cross-functional teams to successfully implement clinical strategic plans, increasing operational efficiency by 20% and accelerating trial timelines.Examples of some studies I have worked on:Bayer AG, Leverkusen:Study of a pediatric nifurtimox formulation for Chagas disease.Merck Sharp & Dohme Corp:Chronic cough in adults (MK-7264)Teva Branded Pharmaceutical Products R&D, Inc.:Tourette's syndrome (ST) (TEV-50717)Janssen Research & Development, LLC:Active Systemic Lupus Erythematosus (Ustekinumab)Merck Sharp & Dohme Corp:Premature infants (MK-1654)Daiichi Sankyo, Inc.Pediatric subjects with venous thromboembolism (Edoxaban)AstraZeneca PLCInfants entering their first RSV season (MEDI8897)Esperion Therapeutics, Inc.Patients with cardiovascular disease (Bempedoic acid, ETC-1002)AbbVie Inc.Moderate to Severe Atopic Dermatitis (Upadacitinib)CSL Behring LLCAcute coronary syndrome (CSL112)GlaxoSmithKline Biologicals SAPregnancy outcomes and incidence in infants of RSVNovartisSacubitril/valsartan compared with enalapril in patients with Chagas cardiomyopathyPfizerCardiovascular Risk Factors and Treatment in General Practice PatientsSanofi Aventis Group, SAGAdult atopic dermatitis patientsHamilton Health Sciences through Population Health Research InstituteCongestive Heart Failure (G‐CHF)AmgenClinical characteristics of subjects prior to initiation of RepathaGeneOneZika IgM assay to detect incident Zika virus infectionWHOImmunogenicity of Inactivated Poliovirus Vaccine (IPV)Johnson & JohnsonCOVID-19 vaccine (VAC31518COV3001)
Member Of The International Committee Of The Brand Of The Marine Foundation
CurrentStrategic Fundraising:• Executed strategic fundraising initiatives to secure financial support for the Marine Foundation's mission. For example, secured $200k funding from a donor by utilizing a robust global network, demonstrating exceptional fundraising acumen.• Implemented innovative fundraising campaigns that effectively communicated the foundation's goals and garnered positive attention.Stakeholder Engagement:• Established and nurtured relationships with key stakeholders, including donors, partners, and community leaders, fostering a collaborative network of support.• Conducted presentations and engagement activities to effectively communicate the foundation's vision and initiatives.
Legal Officer
Current• Developed Jordan Red, the top-ranking bull worldwide, generating $1.5M in revenue through global semen sales in 51 countries, solidifying the brand’s global presence.• Boosted market share in 15 countries by implementing a data-driven marketing strategy, leading to a 35% increase in revenue and expanding into three new regions.• Drove international sales and marketing efforts, leading to strong growth in product distribution, and cultivated key partnerships with leading industry players.
Sales Manager - Latin America
• Conducted comprehensive market analysis across Latin America, identifying untapped opportunities leading to market penetration in the region.• Improved product innovation and market expansion, opening 5 new markets in Latin America.• Negotiated and closed contracts worth $1M across Latin American markets, ensuring long-term partnerships and resolving contractual disputes.• Making deals, negotiating contracts, managing conflictshttp://www.abcgenetics.com/
Clinical Trial Manager
• Established and operationalized a new clinical trial site, enabling participation in over 10 trials within the first 2 years.Examples of some studies I have worked on:Merck Sharp & DohmeSPIRO:A 26-week randomized, double-blinded, active controlled study comparing the safety of mometasone furoate/formoterol fumarate MDI fixed dose combination versus mometasone furoate MDI monotherapy in adolescents and adults with persistent asthma.BPL (Bio Products Laboratory Ltd)OPTIVE:Multicentre, non-controlled, prospective, post-marketing safety study following long-term prophylactic Optivate® treatment in subjects with severe haemophilia A.Janson & JansonMARINER:Global trial to evaluate prophylactic safety and efficacy of extended treatment with an orally administered anticoagulant, rivaroxaban, in high risk medically ill patients for the prevention of venous thromboembolic events (VTE), including pulmonary embolism (PE). TrombosisJanson & JansonCREDENCE:(Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation)Randomized, double-blind, event-driven, placebo-controlled, multicenter study of the effects of Canagliflozin on renal and cardiovascular outcomes in subjects with type 2 diabetes mellitus and diabetic nephropathy.
Research And Development Specialist
Agroscope Changins-Wädenswil Research Center
Development of crops with higher resistance to diseases
Michael Schrago education
Master Of Science (Msc) In Medical Biology, Specialization In Pharmacology
Bachelor Of Science (Bsc), Biology/Biological Sciences, General
Frequently asked questions about Michael Schrago
Quick answers generated from the profile data available on this page.
What company does Michael Schrago work for?
Michael Schrago works for ABC GENETICS.
What is Michael Schrago's role at ABC GENETICS?
Michael Schrago is listed as Legal Officer at ABC GENETICS.
Where is Michael Schrago based?
Michael Schrago is based in Geneva, Switzerland while working with ABC GENETICS.
What companies has Michael Schrago worked for?
Michael Schrago has worked for Abc Genetics, Ipsum Clinical, Marine Foundation, Hospital General De Medellín, and Agroscope Changins-Wädenswil Research Center.
How can I contact Michael Schrago?
You can use AeroLeads to view verified contact signals for Michael Schrago at ABC GENETICS, including work email, phone, and LinkedIn data when available.
What schools did Michael Schrago attend?
Michael Schrago holds Master Of Science (Msc) In Medical Biology, Specialization In Pharmacology from University Of Lausanne - Unil.
What skills is Michael Schrago known for?
Michael Schrago is listed with skills including Biotechnology, Molecular Biology, Lifesciences, Biochemistry, Pcr, Cell Culture, Microbiology, and Sds Page.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial